Trending Now
CytoDyn (OTCMKTS:CYDY) Investor Update Unveils Coming Uplisting and Potential Interim Readout...
Yesterday CytoDyn Inc. (OTCMKTS) delivered a gripping investor update after hours clearly projecting a bright path forward that...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
The USPTO Grants An Innovative Composition Of Matter Patent To Alterity...
Alterity Therapeutics Ltd (NASDAQ: ATHE) received a new patent from the USPTO (The United States Patent and Trademark Office).
With this new patent, Alterity can...
MAKE IT MODERN
LATEST REVIEWS
ARCA Biopharma Inc. (NASDAQ:ABIO) Is Developing AB201Program As A Possible COVID-19...
ARCA Biopharma Inc. (NASDAQ:ABIO) is developing a new program for evaluating AB201 (rNAPc2). It is a selective tissue factor inhibitor for treating coronavirus related...
MAKE IT MODERN
PERFORMANCE TRAINING
IGM Biosciences Inc. (NASDAQ: IGM) Reports Progress in Development of its SARS-CoV-2 IgM Monoclonal ...
IGM Biosciences Inc. (NASDAQ: IGM) has announced progress in two Phase I clinical studies evaluating an anti-SARS-CoV-2 IgM monoclonal antibody, IGM-6268, for prevention and...
Qualigen Therapeutics Inc (NASDAQ: OLGN) Presents Three Posters at the American Association of Cancer...
Qualigen Therapeutics (NASDAQ: OLGN) announced the presentation of three posters at the American Association of Cancer Research, New Orleans.
Affimed NV (NASDAQ:AFMD) And NKMax America Sign Collaborative Deal To Study A AFM24 and...
Affimed NV (NASDAQ:AFMD) recently announced that it signed a collaborative agreement with NKMax America Inc., through which they will both investigate a combination therapy...
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) Announces Q3 2020 Revenue Of $2.29 Boosted Mainly By EYLEA®...
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) has announced its Q3 2020 financial results reporting 32% YoY increase in revenue to $2.29 billion and provided corporate updates.
Regeneron...
Axsome Therapeutics Inc. (NASDAQ: AXSM) Amends Its Term Loan Facility Agreement
Axsome Therapeutics Inc. (NASDAQ: AXSM) has announced the amendment of its current term loan facility agreement with Hercules Capital Inc. (NYSE: HTGC).
Axsome increases its...
MAKE IT MODERN
